Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Reckitt Benckiser Group Plc's Subsidiary Exercises Option To Acquire 25% Interest In Beleggingsmaatschappij Lemore B.V
Reckitt Benckiser Group Plc announced that on May 31, 2012, Reckitt Benckiser Group plc via one of its subsidiaries exercised its option to acquire the final 25% interest in Beleggingsmaatschappij Lemore B.V., the Dutch holding company of its Russian joint venture, Medcom MP, from Abraca B.V. This company was purchased as part of the SSL acquisition in November 2010. Terms of the transaction were not disclosed.
Latest Developments for Reckitt Benckiser Group PLC
- Reckitt Benckiser Group Plc Reaffirms FY 2013 Revenue Guidance-Conference Call
- Reckitt Benckiser Group Plc Receives FDA Response To Citizen's Petition And Announcement of Generics Approval
- Reckitt Benckiser Group Plc Recommends Dividend-News Bites
- Reckitt Benckiser Group Plc Issues FY 2013 Revenue Guidance Above Analysts' Estiamtes-Conference Call
Latest Key Developments in Household
- Share this
- Link this
- Digg this
Follow Reuters